Baker Bros. Advisors
Biotech Investor · 4 portfolio companies
Portfolio
4
Combined Value
$5.6B
Focus Areas
9
Top Stage
Phase 2
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Xenon Pharmaceuticals | $5.2B |
| Keros Therapeutics | $333.9M |
| TScan Therapeutics | $59.2M |
| HOOKIPA Pharma | $12.9M |